ENZO BIOCHEM INC 4/A SEC Filings

Filed On	Filing
29 Apr 2020	Form 4/A: Clemens Peter J Iv, Director Granted 83,333 Stock Option (to acquire Common Stock)
27 Feb 2020	Form 4/A: Bench David, CHIEF FINANCIAL OFFICER Granted 55,400 Stock Option (to acquire Common Stock)
27 Feb 2020	Form 4/A: Weiner Barry W, Director Granted 116,900 Stock Option (to acquire Common Stock)
27 Feb 2020	Form 4/A: Rabbani Elazar, Director Granted 130,100 Stock Option (to acquire Common Stock)
17 Nov 2011	Form 4/A: Weiner Barry W, Director Bought 20,000 shares ($45.7K)
04 Nov 2008	Form 4/A: Balezentis Carl W, President, Enzo Life Sciences Sold 580 shares ($3.1K)
13 Jun 2007	Form 4/A: Delucca John, Director Received 15,194 shares by exercise or conversion ($107K)
01 Jun 2005	Form 4/A: Goldberg David C, VP, Business Development Received 7,035 shares by exercise or conversion ($48.1K)
17 Aug 2004	Form 4/A: Goldberg David C, Vice President, Bus. Dev. Received 3,350 shares by exercise or conversion ($24.4K) · Acquired 3,350 Incentive Stock Option (Option Exercise/Conversion)
17 Aug 2004	Form 4/A: Thalenfeld Barbara E, VP, Corporate Development Received 3,350 shares by exercise or conversion ($24.4K) · Acquired 3,350 Incentive Stock Option (Option Exercise/Conversion)
29 Apr 2004	Form 4/A: Rabbani Elazar, Director Received 284,138 shares by exercise or conversion ($2.09M) · Gave up 129,248 shares to cover exercise price or tax ($2.09M)
29 Apr 2004	Form 4/A: Rabbani Shahram K, Director Received 284,138 shares by exercise or conversion ($2.09M) · Gave up 129,248 shares to cover exercise price or tax ($2.09M)
29 Apr 2004	Form 4/A: Weiner Barry W, Director Received 201,014 shares by exercise or conversion ($1.48M) · Gave up 91,437 shares to cover exercise price or tax ($1.48M)
26 Apr 2004	Form 4/A: Goldberg David C, VP of Business Development Acquired 6,700 Incentive Stock Option (Option Exercise/Conversion)
30 Mar 2004	Form 4/A: Lazar Melvin F, Director Bought 5,125 shares ($81K)

Comments